Jacobson Pharma Corporation Limited (HKG:2633)
Hong Kong
· Delayed Price · Currency is HKD 1.180
+0.020 (1.72%)
Mar 21, 2025, 4:08 PM HKT
HKG:2633 Revenue
Jacobson Pharma Corporation had revenue of 810.00M HKD in the half year ending September 30, 2024, with 39.20% growth. This brings the company's revenue in the last twelve months to 1.56B, up 11.58% year-over-year. In the fiscal year ending March 31, 2024, Jacobson Pharma Corporation had annual revenue of 1.47B with 15.79% growth.
Revenue (ttm)
1.56B
Revenue Growth
+11.58%
P/S Ratio
1.48
Revenue / Employee
903.40K
Employees
1,723
Market Cap
2.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1.47B | 200.20M | 15.79% |
| Mar 31, 2023 | 1.27B | -327.95M | -20.55% |
| Mar 31, 2022 | 1.60B | 149.63M | 10.35% |
| Mar 31, 2021 | 1.45B | -125.54M | -7.99% |
| Mar 31, 2020 | 1.57B | 93.33M | 6.31% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| WuXi Biologics | 18.39B |
| JD Health International | 61.89B |
| Alibaba Health Information Technology | 31.39B |
| Innovent Biologics | 8.01B |
| Sino Biopharmaceutical | 29.86B |
| Akeso | 2.01B |